Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 145
Filter
1.
Anal Chem ; 96(16): 6390-6397, 2024 Apr 23.
Article in English | MEDLINE | ID: mdl-38608159

ABSTRACT

Although gastric cancer (GC) is one of the most frequent malignant tumors in the digestive tract with high morbidity and mortality, it remains a diagnostic dilemma due to its reliance on invasive biopsy or insensitive assays. Herein, we report a fluorescent gastric cancer reporter (FGCR) with activatable near-infrared fluorescence (NIRF) signals and high renal-clearance efficiency for the detection of orthotopic GC in a murine model via real-time imaging and remote urinalysis. In the presence of gastric-tumor-associated ß-galactosidase (ß-Gal), FGCR can be fluorescently activated for in vivo NIRF imaging. Relying on its high renal-clearance efficiency (∼95% ID), it can be rapidly excreted through kidneys to urine for the ultrasensitive detection of tumors with a diameter down to ∼2.1 mm and for assessing the prognosis of oxaliplatin-based chemotherapy. This study not only provides a new approach for noninvasive auxiliary diagnosis and prognosis of GC but also provides guidelines for the development of fluorescence probes for cancer diagnosis.


Subject(s)
Fluorescent Dyes , Optical Imaging , Stomach Neoplasms , beta-Galactosidase , Stomach Neoplasms/diagnosis , Stomach Neoplasms/urine , Stomach Neoplasms/pathology , Animals , beta-Galactosidase/metabolism , Fluorescent Dyes/chemistry , Humans , Mice , Cell Line, Tumor , Mice, Nude
2.
J Chromatogr A ; 1653: 462422, 2021 Sep 13.
Article in English | MEDLINE | ID: mdl-34348207

ABSTRACT

Gastric carcinoma is one of the most common and deadly forms of cancer. Early detection is critical for successful treatment of gastric cancer, and examination of BAs in urine may provide a critical diagnostic tool for identifying gastric cancer at stages when it can still be cured. Bile acids (BAs) are a crucial toxic factor correlated with the injury of gastric mucosa and as such, quantifying the amount of BA in patient's urine could provide a new means to quickly and non-invasively identify the presence of gastric cancer in the early stages. Here, a covalent organic framework (COF) material synthesized on the basis of 1,3,5-tris(4-nitrophenyl)benzene (TAPB) and pyromellitic dianhydride (PMDA) was used as stationary phase for SPE column that was coupled to LC-MS/MS for quantitative analysis of eight BAs in human urine, including cholic acid (CA), deoxycholic acid (DCA), glycochenodeoxycholic acid (GCDCA), glycocholic acid (GCA), taurochenodeoxycholic acid (TCDCA), lithocholic acid (LCA), hyodeoxycholic acid (HDCA), and chenodeoxycholic acid (CDCA). The enrichment effect of synthesized COF material was better than commercial SPE and HLB column. The sensitivity can increase 9.37- to 54.30- fold (calculated by the ratio of peak area between before and after enrichment). The probable mechanism is due to the great porosity and the similar polarity with BAs of the COF material. By compared with previous literatures, our method had the minimum limit of detection, which achieved 46.40, 25.75, 47.40, 47.37, 30.42, and 33.92 pg /mL, respectively, for GCA, GCDCA, CA, CDCA, HDCA and DCA after enrichment. These eight BAs also accomplished excellent linearity from 0.34 to 10,000 ng/mL. This material was successfully applied in the measurements of these six BAs in human urine from 76 gastric cancer patients and 32 healthy people. Compared to healthy people, levels of CA, CDCA, DCA, and HDCA were significantly elevated and levels of GCDCA were depressed, respectively, in gastric cancer patients. Our work suggests that these acids may act as potential biomarkers for gastric cancer and our framework provides a method for "non-invasive" diagnosis of gastric cancer.


Subject(s)
Bile Acids and Salts , Chromatography, Liquid , Stomach Neoplasms , Tandem Mass Spectrometry , Bile Acids and Salts/urine , Humans , Stomach Neoplasms/urine , Urinalysis
3.
Mikrochim Acta ; 188(3): 66, 2021 02 04.
Article in English | MEDLINE | ID: mdl-33543311

ABSTRACT

A magnetic porous carbon-dependent platform is established to separate and determine N-glycans from urine exosomes of healthy people and patients with gastric cancer. The results of the comparison reveal that 6 N-glycans shared by the two groups are downregulated, most of which present core fucose or bisecting N-acetylglucosamine (GlcNAc) type. In addition, five shared N-glycans including two of sialic acid type are upregulated. These obvious differences indicate the close relationship between glycans and gastric cancer thus permitting early diagnosis. A magnetic porous carbon material (FeMPC) from MIL-101(Fe) was employed to separate and analyze N-glycans from urine exosomes of healthy people and patients with gastric cancer.


Subject(s)
Carbon/chemistry , Exosomes/chemistry , Polysaccharides/urine , Stomach Neoplasms/urine , Urine/cytology , Adsorption , Humans , Iron/chemistry , Magnetic Phenomena , Metal-Organic Frameworks/chemical synthesis , Metal-Organic Frameworks/chemistry , Polysaccharides/chemistry , Porosity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Stomach Neoplasms/diagnosis
4.
Br J Cancer ; 123(11): 1656-1664, 2020 11.
Article in English | MEDLINE | ID: mdl-32934343

ABSTRACT

BACKGROUND: With the goal of discovering non-invasive biomarkers for early diagnosis of GC, we conducted a case-control study utilising urine samples from individuals with predominantly early GC vs. healthy control (HC). METHODS: Among urine samples from 372 patients, age- and sex-matched 282 patients were randomly divided into three groups: 18 patients in a discovery cohort; 176 patients in a training cohort and 88 patients in a validation cohort. RESULTS: Among urinary proteins identified in the comprehensive quantitative proteomics analysis, urinary levels of TFF1 (uTFF1) and ADAM12 (uADAM12) were significantly independent diagnostic biomarkers for GC, in addition to Helicobacter pylori status. A urinary biomarker panel combining uTFF1, uADAM12 and H. pylori significantly distinguished between HC and GC patients in both training and validation cohorts. On the analysis for sex-specific biomarkers, this combination panel demonstrated a good AUC of 0.858 for male GC, whereas another combination panel of uTFF1, uBARD1 and H. pylori also provided a good AUC of 0.893 for female GC. Notably, each panel could distinguish even stage I GC patients from HC patients (AUC = 0.850 for males; AUC = 0.845 for females). CONCLUSIONS: Novel urinary protein biomarker panels represent promising non-invasive biomarkers for GC, including early-stage disease.


Subject(s)
Biomarkers, Tumor/urine , Early Detection of Cancer/methods , Stomach Neoplasms/diagnosis , Stomach Neoplasms/urine , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Male , Middle Aged , Sensitivity and Specificity
5.
Mikrochim Acta ; 187(7): 388, 2020 06 15.
Article in English | MEDLINE | ID: mdl-32542460

ABSTRACT

A novel magnetic organic porous polymer (denoted as Fe3O4@PC-POP) was developed for magnetic solid-phase extraction (MSPE) of two gastric cancer biomarkers (P-cresol and 4-hydroxybenzoic acid) from urine samples prior to high-performance liquid chromatographic analysis. The adsorbent was characterized by scanning electron microscope, transmission electron microscope, FTIR, powder X-ray diffraction, and other techniques. The result of dynamic light scattering shows that the particle size of the adsorbent is mainly distributed around 400 nm. Based on the design concept of the Fe3O4@PC-POP, the proposed material can effectively capture the target analytes through electrostatic and hydrophobic interaction mechanism. Furthermore, the enrichment conditions were optimized by the response surface method, and the method was utilized for the determination of P-cresol and 4-hydroxybenzoic acid in real urine samples from health and gastric cancer patients with high enrichment factors (34.8 times for P-cresol and 38.7 times for 4-hydroxybenzoic acid), low limit of detection (0.9-5.0 µg L-1), wide linear ranges (3.0-1000 µg L-1), satisfactory relative standard deviation (2.5%-8.5%), and apparent recoveries (85.3-112% for healthy people's and 86.0-112% for gastric cancer patients' urine samples). This study provides a guided principle for design of the versatile polymer with specific capturing of the target compounds from complex biological samples. Graphical abstract.


Subject(s)
Biomarkers, Tumor/urine , Cresols/urine , Magnetite Nanoparticles/chemistry , Parabens/analysis , Polymers/chemistry , Stomach Neoplasms/urine , Adsorption , Biomarkers, Tumor/chemistry , Biomarkers, Tumor/isolation & purification , Chromatography, High Pressure Liquid , Cresols/chemistry , Cresols/isolation & purification , Humans , Limit of Detection , Parabens/chemistry , Parabens/isolation & purification , Piperazines/chemistry , Porosity , Solid Phase Extraction/methods
6.
J Gastroenterol ; 54(12): 1061-1069, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31240436

ABSTRACT

BACKGROUND: Gastric cancer (GC) is one of the most common causes of cancer deaths worldwide; however, reliable and non-invasive screening methods for GC are not established. Therefore, we conducted this study to develop a biomarker for GC detection, consisting of urinary microRNAs (miRNAs). METHODS: We matched 306 participants by age and sex [153 pairs consisting of patients with GC and healthy controls (HCs)], then randomly divided them across three groups: (1) the discovery cohort (4 pairs); (2) the training cohort (95 pairs); and (3) the validation cohort (54 pairs). RESULTS: There were 22 urinary miRNAs with significantly aberrant expressions between the two groups in the discovery cohort. Upon multivariate analysis of the training cohort, urinary expression levels of miR-6807-5p and miR-6856-5p were significantly independent biomarkers for diagnosis of GC, in addition to Helicobacter pylori (H. pylori) status. A diagnostic panel that combined these 2 miRNAs and H. pylori status distinguished between HC and GC samples with an area under the curve (AUC) = 0.736. In the validation cohort, urinary miR-6807-5p and miR-6856-5p showed significantly higher expression levels in the GC group, and the combination biomarker panel of miR-6807-5p, miR-6856-5p, and H. pylori status also showed excellent performance (AUC = 0.885). In addition, this biomarker panel could distinguish between HC and stage I GC patients with an AUC = 0.748. Urinary expression levels of miR-6807-5p and miR-6856-5p significantly decreased to undetectable level after curative resection of GC. CONCLUSIONS: This novel biomarker panel enables early and non-invasive detection of GC.


Subject(s)
Biomarkers, Tumor/urine , Helicobacter pylori/isolation & purification , MicroRNAs/urine , Stomach Neoplasms/diagnosis , Aged , Biomarkers, Tumor/genetics , Case-Control Studies , Female , Helicobacter Infections/epidemiology , Humans , Male , Middle Aged , Neoplasm Staging , Stomach Neoplasms/genetics , Stomach Neoplasms/urine
7.
Ann Biol Clin (Paris) ; 77(2): 161-168, 2019 04 01.
Article in French | MEDLINE | ID: mdl-30998196

ABSTRACT

OBJECTIVES: Platelet serotonin and its urinary metabolite 5-HIAA (5-hydroxyindolacetic acid) are the main biomarkers measured for the detection of neuroendocrine tumors (NET). We observe in our laboratory many false positives or false negatives for the 2 assays using threshold values given by the manufacturer. We aim to determine our own local threshold values for a better detection of gastrointestinal NETs. METHODS: We studied patients with measurement of platelet serotonin and/or urinary 5-HIAA in University Hospital of Tours between January 2005 and June 2016. We established an « index ¼ cohort with 75% of patients to determine local threshold value for the 2 parameters. A "validation" cohort constituted with 25% of remaining patients allowed us to compare the performances of manufacturer's values with local threshold values. RESULTS: Two hundred ninety patients were included, with 19 suffering from NETs. Local threshold value for platelet serotonin was determined at 5.13 amol/platelet, the one for urinary 5-HIAA at 3.60 µmol/mmol urinary creatinine. Platelet serotonin specificity was better with local threshold value for identical sensibility (0.75). Urinary 5-HIAA sensibility was improved with local threshold value (1 vs 0.667) for identical specificity (0.902). CONCLUSION: Using our local threshold value for platelet serotonin and urinary 5-HIAA improved diagnostic performances of these biochemical markers to detect NETs.


Subject(s)
Blood Chemical Analysis/methods , Blood Platelets/chemistry , Digestive System Neoplasms/diagnosis , Hydroxyindoleacetic Acid/urine , Neuroendocrine Tumors/diagnosis , Serotonin/analysis , Urinalysis/methods , Adult , Aged , Biomarkers/blood , Biomarkers/urine , Blood Chemical Analysis/standards , Blood Platelets/metabolism , Cohort Studies , Digestive System Neoplasms/blood , Digestive System Neoplasms/urine , Female , Humans , Hydroxyindoleacetic Acid/analysis , Intestinal Neoplasms/blood , Intestinal Neoplasms/diagnosis , Intestinal Neoplasms/urine , Male , Middle Aged , Neuroendocrine Tumors/blood , Neuroendocrine Tumors/urine , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/urine , Reference Values , Retrospective Studies , Serotonin/blood , Stomach Neoplasms/blood , Stomach Neoplasms/diagnosis , Stomach Neoplasms/urine
8.
Talanta ; 191: 133-140, 2019 Jan 01.
Article in English | MEDLINE | ID: mdl-30262042

ABSTRACT

Analyzing of tumor markers has become an important means for cancer diagnosis and prevention. In this study, a novel solid phase extraction based on porous magnetic cyclodextrin polymer (MA-CD) was developed and used for detection of trace small molecule gastric tumor markers in urine samples. The adsorption properties of the magnetic cyclodextrin polymer were tested. Through experiments of the solid phase extraction (SPE) at the different condition, the optimal condition was selected to test the two tumor markers by High-performance-liquid chromatography -Diode array detector (HPLC-DAD). The analytical performance of the method showed good accuracy (88.82%-104.34%) and precision (< 3.55%), appropriated detection limits (1.016 and 5.714 µg L-1) and linear ranges (0.6-24.0 µg L-1) with convenient determination coefficients (> 0.9994). The results demonstrated that the developed approach is efficient, low-cost for gastric tumor markers detection.


Subject(s)
Cresols/urine , Magnets/chemistry , Parabens/analysis , Solid Phase Extraction/methods , Stomach Neoplasms/diagnosis , Urinalysis/methods , beta-Cyclodextrins/chemistry , Adsorption , Biomarkers, Tumor/isolation & purification , Biomarkers, Tumor/urine , Cresols/isolation & purification , Early Detection of Cancer , Humans , Hydrogen-Ion Concentration , Kinetics , Limit of Detection , Parabens/isolation & purification , Porosity , Stomach Neoplasms/urine
9.
J Biophotonics ; 12(4): e201800327, 2019 04.
Article in English | MEDLINE | ID: mdl-30447050

ABSTRACT

Modified nucleoside in urine samples is one of the most common biomarkers for cancer screening. Therefore, we developed a novel detection method for modified nucleoside detection in human urine. In this work, the modified nucleoside from real cancer patient's urine samples was first separated and purified using the affinity chromatography (AC) technology relying on its specific adsorption capacity. Then, surface-enhanced Raman spectroscopy (SERS) technology with the capability of single molecular detection was used to sensitively characterize the biomolecular features of modified nucleoside. A total of 141 high-quality SERS spectra of urinary modified nucleoside can be obtained from 50 gastric cancer patients and 43 breast cancer patients, as well as 48 healthy volunteers. Using principal component analysis combined with linear discriminant analysis (PCA-LDA), the diagnostic sensitivities for identifying gastric cancer vs normal, breast cancer vs normal, gastric cancer vs breast cancer were 84.0%, 76.7% and 82.0%, respectively, and the corresponding diagnostic specificities for each combination were 95.8%, 87.5% and 90.7%, respectively. These results show that this novel method based on urinary modified nucleoside detection combining AC and SERS technologies holds promising potential for developing a specific, non-invasive and label-free tool for cancer screening.


Subject(s)
Chromatography, Affinity , Gold/chemistry , Mass Screening , Metal Nanoparticles/chemistry , Neoplasms/urine , Spectrum Analysis, Raman , Urinalysis/methods , Breast Neoplasms/diagnosis , Breast Neoplasms/urine , Humans , Neoplasms/diagnosis , Sensitivity and Specificity , Stomach Neoplasms/diagnosis , Stomach Neoplasms/urine
10.
Cancer Res ; 79(3): 676-684, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30563886

ABSTRACT

Studies on a longitudinal relationship between smoking status and intestinal metaplasia (IM), a premalignant lesion of stomach cancer, are limited. Here we examined the association of smoking status and urinary cotinine levels, an objective measure of smoking, with the development of endoscopic IM. This cohort study included 199,235 Korean adults free of endoscopic IM who underwent upper endoscopy at baseline and subsequent visits and who were followed for up to 6.8 years (median, 3.7 years). Former and current smoking status and pack-years based on self-reports were associated with an increased risk of new-onset IM in men but not in women. However, urinary cotinine levels were positively associated with incident IM in a dose-response manner in both men and women. For men, the multivariable-adjusted HR [95% confidence interval (CI)] for incident IM comparing the urinary cotinine levels of 50 to 99 ng/mL, 100 to 499 ng/mL, and ≥500 ng/mL with <50 ng/mL were 1.20 (0.94-1.55), 1.26 (1.14-1.40), and 1.54 (1.44-1.64), respectively, whereas for women, corresponding HR (95% CI) were 0.75 (0.19-2.99), 1.86 (1.20-2.88), and 1.57 (1.07-2.30), respectively. These associations were observed when changes in smoking status and other confounders were updated during follow-up as time-varying covariates. In this large cohort of young and middle-aged men and women, urinary cotinine levels were independently associated with an increased incidence of endoscopic IM in a dose-response manner. Collectively, these data confirm smoking as an independent risk factor for the development of gastric IM, a precursor lesion of stomach cancer. SIGNIFICANCE: A large-scale cohort study of nearly 200,000 adults associates smoking with increased risk for gastric intestinal metaplasia, a precursor lesion of stomach cancer.


Subject(s)
Cotinine/urine , Gastric Mucosa/pathology , Intestinal Mucosa/pathology , Precancerous Conditions/urine , Adult , Cohort Studies , Female , Humans , Male , Metaplasia/epidemiology , Metaplasia/pathology , Metaplasia/urine , Precancerous Conditions/epidemiology , Precancerous Conditions/pathology , Republic of Korea/epidemiology , Smoking/epidemiology , Smoking/pathology , Smoking/urine , Stomach Neoplasms/epidemiology , Stomach Neoplasms/pathology , Stomach Neoplasms/urine
11.
Tumour Biol ; 39(2): 1010428317691681, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28222666

ABSTRACT

The mutations of epidermal growth factor receptor are detected in gastric cancer, indicating its suitability as a target for receptor tyrosine kinase inhibitors, as well as a marker for clinical outcome of chemotherapeutic treatments. However, extraction of quality tumor tissue for molecular processes remains challenging. Here, we aimed to examine the clinical relevance of urinary cell-free DNA as an alternative tumor material source used specifically for monitoring epidermal growth factor receptor mutations. Therefore, 120 gastric cancer patients with epidermal growth factor receptor mutations and 100 healthy controls were recruited for the study. The gastric patients also received epidermal growth factor receptor inhibitor treatment for a serial monitoring study. Paired primary tumor specimens were obtained with blood and urine samples, which were taken at a 1-month interval for a duration of 12 months. We found that urinary cell-free DNA yielded a close agreement of 92% on epidermal growth factor receptor mutation status when compared to primary tissue at baseline, and of 99% epidermal growth factor receptor mutation status when compared to plasma samples at different time points. Thus, our data suggest that urinary cell-free DNA may be a reliable source for screening and monitoring epidermal growth factor receptor mutations in the primary gastric cancer.


Subject(s)
DNA, Neoplasm/urine , ErbB Receptors/genetics , Mutation , Stomach Neoplasms/genetics , Case-Control Studies , DNA, Neoplasm/blood , Female , Humans , Male , Middle Aged , Stomach Neoplasms/blood , Stomach Neoplasms/urine
12.
Oncotarget ; 7(52): 87496-87510, 2016 Dec 27.
Article in English | MEDLINE | ID: mdl-27589838

ABSTRACT

Early diagnosis of gastric cancer is crucial to improve patient' outcome. A good biomarker will function in early diagnosis for gastric cancer. In order to find practical and cost-effective biomarkers, we used gas chromatography combined mass spectrometer (GC-MS) to profile urinary metabolites on 293 urine samples. Ninety-four samples are taken as training set, others for validating study. Orthogonal partial least squares discriminant analysis (OPLS-DA), significance analysis of microarray (SAM) and Mann-Whitney U test are used for data analysis. The diagnostic value of urinary metabolites was evaluated by ROC curve. As results, Seventeen metabolites are significantly different between patients and healthy controls in training set. Among them, 14 metabolites show diagnostic value better than classic blood biomarkers by quantitative assay on validation set. Ten of them are amino acids and four are organic metabolites. Importantly, proline, p-cresol and 4-hydroxybenzoic acid disclose outcome-prediction value by means of survival analysis. Therefore, the examination of urinary metabolites is a promising noninvasive strategy for gastric cancer screening.


Subject(s)
Gas Chromatography-Mass Spectrometry/methods , High-Throughput Screening Assays/methods , Stomach Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , Amino Acids/urine , Biomarkers, Tumor/urine , Early Detection of Cancer , Female , Humans , Male , Metabolic Networks and Pathways , Middle Aged , ROC Curve , Stomach Neoplasms/mortality , Stomach Neoplasms/urine
13.
Br J Cancer ; 114(1): 59-62, 2016 Jan 12.
Article in English | MEDLINE | ID: mdl-26645240

ABSTRACT

BACKGROUND: Metabolomics has shown promise in gastric cancer (GC) detection. This research sought to identify whether GC has a unique urinary metabolomic profile compared with benign gastric disease (BN) and healthy (HE) patients. METHODS: Urine from 43 GC, 40 BN, and 40 matched HE patients was analysed using (1)H nuclear magnetic resonance ((1)H-NMR) spectroscopy, generating 77 reproducible metabolites (QC-RSD <25%). Univariate and multivariate (MVA) statistics were employed. A parsimonious biomarker profile of GC vs HE was investigated using LASSO regularised logistic regression (LASSO-LR). Model performance was assessed using Receiver Operating Characteristic (ROC) curves. RESULTS: GC displayed a clear discriminatory biomarker profile; the BN profile overlapped with GC and HE. LASSO-LR identified three discriminatory metabolites: 2-hydroxyisobutyrate, 3-indoxylsulfate, and alanine, which produced a discriminatory model with an area under the ROC of 0.95. CONCLUSIONS: GC patients have a distinct urinary metabolite profile. This study shows clinical potential for metabolic profiling for early GC diagnosis.


Subject(s)
Magnetic Resonance Spectroscopy/methods , Metabolomics/methods , Stomach Neoplasms/diagnosis , Aged , Female , Humans , Logistic Models , Male , Middle Aged , Stomach Neoplasms/urine
14.
World J Gastroenterol ; 21(47): 13240-9, 2015 Dec 21.
Article in English | MEDLINE | ID: mdl-26715806

ABSTRACT

AIM: To study histidine decarboxylase (HDC) expression in normal and neoplastic gastric neuroendocrine cells in relationship to the main histamine metabolite. METHODS: Control tissues from fundus (n = 3) and corpus (n = 3) mucosa of six patients undergoing operations for gastric adenocarcinoma, biopsy and/or gastric surgical specimens from 64 patients with primary gastric neuroendocrine tumours (GNETs), as well as metastases from 22 of these patients, were investigated using conventional immunohistochemistry and double immunofluorescence with commercial antibodies vs vesicular monoamine transporter 2 (VMAT-2), HDC and ghrelin. The urinary excretion of the main histamine metabolite methylimidazoleacetic acid (U-MeImAA) was determined using high-performance liquid chromatography in 27 of the 64 patients. RESULTS: In the gastric mucosa of the control tissues, co-localization studies identified neuroendocrine cells that showed immunoreactivity only to VMAT-2 and others with reactivity only to HDC. A third cell population co-expressed both antigens. There was no co-expression of HDC and ghrelin. Similar results were obtained in the foci of neuroendocrine cell hyperplasia associated with chronic atrophic gastritis type A and also in the tumours. The relative incidence of the three aforementioned markers varied in the tumours that were examined using conventional immunohistochemistry. All of these GNETs revealed both VMAT-2 and HDC immunoreactivity, and their metastases showed an immunohistochemical pattern and frequency similar to that of their primary tumours. In four patients, increased U-MeImAA excretion was detected, but only two of the patients exhibited related endocrine symptoms. CONCLUSION: Human enterochromaffin-like cells appear to partially co-express VMAT-2 and HDC. Co-expression of VMAT-2 and HDC might be required for increased histamine production in patients with GNETs.


Subject(s)
Adenocarcinoma/enzymology , Biomarkers, Tumor/urine , Enterochromaffin Cells/enzymology , Histidine Decarboxylase/analysis , Imidazoles/urine , Neuroendocrine Cells/enzymology , Neuroendocrine Tumors/enzymology , Stomach Neoplasms/enzymology , Adenocarcinoma/secondary , Adenocarcinoma/urine , Adult , Aged , Aged, 80 and over , Chromatography, High Pressure Liquid , Enterochromaffin Cells/pathology , Female , Fluorescent Antibody Technique , Ghrelin/analysis , Humans , Male , Middle Aged , Neuroendocrine Cells/pathology , Neuroendocrine Tumors/secondary , Neuroendocrine Tumors/urine , Renal Elimination , Stomach Neoplasms/pathology , Stomach Neoplasms/urine , Urinalysis , Vesicular Monoamine Transport Proteins/analysis , Young Adult
15.
Appl Biochem Biotechnol ; 176(8): 2170-84, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26088916

ABSTRACT

Metabolomics is a post-genomics research field for analysis of low molecular weight compounds in biological samples and has shown great potentials for elucidating complex mechanisms associated with diseases. However, metabolomics studies on gastric cancer (GC), which is the second leading cause of cancer death worldwide, remain scarce, and the molecular mechanisms to metabolomics phenotypes are also still not fully understood. This study reports that the metabolic pathways can be exploited as biomarkers for diagnosis and treatment of GC progression as a case study. Importantly, the urinary metabolites and metabolic patterns were analyzed by high-throughput liquid chromatography mass spectrometry (LC-MS) metabolomics strategy coupled with chemometric evaluation. Sixteen metabolites (nine upregulated and seven downregulated) were differentially expressed and may thus serve as potential urinary biomarkers for human GC. These metabolites were mainly involved in multiple metabolic pathways, including citrate cycle (malic acid, succinic acid, 2-oxoglutarate, citric acid), cyanoamino acid metabolism (glycine, alanine), primary bile acid biosynthesis (glycine, taurine, glycocholic acid), arginine and proline metabolism (urea, L-proline), and fatty acid metabolism (hexadecanoic acid), among others. Network analysis validated close association between these identified metabolites and altered metabolic pathways in a variety of biological processes. These results suggest that urine metabolic profiles have great potential in detecting GC and may aid in understanding its underlying mechanisms. It provides insight into disease pathophysiology and can serve as the basis for developing disease biomarkers and therapeutic interventions for GC diseases.


Subject(s)
Chromatography, Liquid/methods , Mass Spectrometry/methods , Metabolomics/methods , Stomach Neoplasms/metabolism , Adult , Biomarkers, Tumor/metabolism , Biomarkers, Tumor/urine , Case-Control Studies , Humans , Metabolic Networks and Pathways , Metabolome , Phenotype , Principal Component Analysis , Stomach Neoplasms/urine
16.
J Gastrointest Cancer ; 46(2): 138-42, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25761643

ABSTRACT

PURPOSE: The aim of this paper is to study urinary5-hydroxyindoleacetic acid (5-HIAA) in gastric cancer patients with a biochemical method and compare this metabolite with normal control and individuals with chronic gastritis. MATERIALS AND METHODS: The subjects were 48 histologically proven gastric adenocarcinoma patients. They were 10 women and 38 men with mean age of 63.73 years. For determination of urinary excretion of 5-HIAA, a biochemical method was applied. According to kit protocol, the patients' fresh urine was added to the reagent material, and the color of the sediment that was the result of interaction between 5-HIAA and the mercury salt was compared with the standard colorimetric plate of the kit. The same method was also performed for a group of 47 patients with chronic gastritis and also a group of 50 normal individuals (age and sex matched). RESULTS: Urinary 5-HIAA was significantly higher in gastric cancer patients compared to individuals with chronic gastritis and normal controls (P value <0.001), but no association was detected in urinary 5-HIAA based on age, sex, or site of tumor and tumor grade in gastric cancer patients group. Also, no significant difference was noted in 5-HIAA excretion between chronic gastritis and normal control groups. CONCLUSION: Urinary excretion of 5-HIAA is significantly higher in the gastric cancer patients in comparison with that of chronic gastritis patients or normal individuals. So, this test could be regarded as a tumor marker in conjunction with other modalities in diagnosis of gastric cancer.


Subject(s)
Biomarkers, Tumor/urine , Gastric Mucosa/metabolism , Hydroxyindoleacetic Acid/urine , Metabolomics , Stomach Neoplasms/urine , Aged , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Grading , Prognosis , Stomach Neoplasms/pathology
17.
PLoS One ; 10(2): e0117326, 2015.
Article in English | MEDLINE | ID: mdl-25658333

ABSTRACT

BACKGROUND: N-Nitroso compounds are thought to play a significant role in the development of gastric cancer. Epidemiological data, however, are sparse in examining the associations between biomarkers of exposure to N-nitroso compounds and the risk of gastric cancer. METHODS: A nested case-control study within a prospective cohort of 18,244 middle-aged and older men in Shanghai, China, was conducted to examine the association between urinary level of N-nitroso compounds and risk of gastric cancer. Information on demographics, usual dietary intake, and use of alcohol and tobacco was collected through in-person interviews at enrollment. Urinary levels of nitrate, nitrite, N-nitroso-2-methylthiazolidine-4-carboxylic acid (NMTCA), N-nitrosoproline (NPRO), N-nitrososarcosine (NSAR), N-nitrosothiazolidine-4-carboxylic acid (NTCA), as well as serum H. pylori antibodies were quantified in 191 gastric cancer cases and 569 individually matched controls. Logistic regression method was used to assess the association between urinary levels of N-nitroso compounds and risk of gastric cancer. RESULTS: Compared with controls, gastric cancer patients had overall comparable levels of urinary nitrate, nitrite, and N-nitroso compounds. Among individuals seronegative for antibodies to H. pylori, elevated levels of urinary nitrate were associated with increased risk of gastric cancer. The multivariate-adjusted odds ratios for the second and third tertiles of nitrate were 3.27 (95% confidence interval = 0.76-14.04) and 4.82 (95% confidence interval = 1.05-22.17), respectively, compared with the lowest tertile (P for trend = 0.042). There was no statistically significant association between urinary levels of nitrite or N-nitroso compounds and risk of gastric cancer. Urinary NMTCA level was significantly associated with consumption of alcohol and preserved meat and fish food items. CONCLUSION: The present study demonstrates that exposure to nitrate, a precursor of N-nitroso compounds, may increase the risk of gastric cancer among individuals without a history of H. pylori infection.


Subject(s)
Nitrates/urine , Nitrites/urine , Nitroso Compounds/urine , Stomach Neoplasms/urine , Case-Control Studies , China/epidemiology , Helicobacter Infections/complications , Helicobacter pylori/isolation & purification , Humans , Middle Aged , Prospective Studies , Risk Factors , Stomach Neoplasms/complications , Stomach Neoplasms/epidemiology , Stomach Neoplasms/microbiology
18.
Proteomics Clin Appl ; 9(5-6): 586-96, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25644331

ABSTRACT

PURPOSE: Cancer of the upper digestive tract (uGI) is a major contributor to cancer-related death worldwide. Due to a rise in occurrence, together with poor survival rates and a lack of diagnostic or prognostic clinical assays, there is a clear need to establish molecular biomarkers. EXPERIMENTAL DESIGN: Initial assessment was performed on urine samples from 60 control and 60 uGI cancer patients using MS to establish a peak pattern or fingerprint model, which was validated by a further set of 59 samples. RESULTS: We detected 86 cluster peaks by MS above frequency and detection thresholds. Statistical testing and model building resulted in a peak profiling model of five relevant peaks with 88% overall sensitivity and 91% specificity, and overall correctness of 90%. High-resolution MS of 40 samples in the 2-10 kDa range resulted in 646 identified proteins, and pattern matching identified four of the five model peaks within significant parameters, namely programmed cell death 6 interacting protein (PDCD6IP/Alix/AIP1), Rabenosyn-5 (ZFYVE20), protein S100A8, and protein S100A9, of which the first two were validated by Western blotting. CONCLUSIONS AND CLINICAL RELEVANCE: We demonstrate that MS analysis of human urine can identify lead biomarker candidates in uGI cancers, which makes this technique potentially useful in defining and consolidating biomarker patterns for uGI cancer screening.


Subject(s)
Biomarkers, Tumor/urine , Calcium-Binding Proteins/urine , Cell Cycle Proteins/urine , Endosomal Sorting Complexes Required for Transport/urine , Esophageal Neoplasms/urine , Stomach Neoplasms/urine , Vesicular Transport Proteins/urine , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/isolation & purification , Calcium-Binding Proteins/isolation & purification , Case-Control Studies , Cell Cycle Proteins/isolation & purification , Chromatography, Affinity , Endosomal Sorting Complexes Required for Transport/isolation & purification , Female , Humans , Male , Middle Aged , Vesicular Transport Proteins/isolation & purification , Young Adult
19.
Cancer Prev Res (Phila) ; 8(3): 240-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25591790

ABSTRACT

Although the early diagnosis of gastric cancer provides the opportunity for curative endoscopic resection, comprehensive screening endoscopy would be invasive and expensive. To date, there is a complete absence of clinically useful gastric cancer biomarkers. With the goal of discovering noninvasive biomarkers for the early diagnosis of gastric cancer, we have conducted a case-control study using urine samples from individuals with gastric cancer versus healthy control samples. Of the enrolled 106 patients from September, 2012 to April, 2013, a cohort of 70 patients composed of 35 patients with gastric cancer and 35 age- and sex-matched healthy controls was analyzed. The gastric cancer group was composed of stage IA of 62.9% (22/35). The urinary levels of MMP-9/NGAL complex (uMMP-9/NGAL) and ADAM12 (uADAM12) were significantly higher in the gastric cancer group compared with the healthy control group as determined by monospecific ELISAs (uMMP-9/NGAL: median, 85 pg/mL vs. 0 pg/mL; P = 0.020; uADAM12: median, 3.35 ng/mL vs. 1.44 ng/mL; P < 0.001). Multivariate analysis demonstrated that both uMMP-9/NGAL and uADAM12 were significant, independent diagnostic biomarkers for gastric cancer. Moreover, MMP-9/NGAL activity was significantly elevated as determined by gelatin zymography. The combination of uMMP-9/NGAL with uADAM12 distinguished between control samples and gastric cancer samples with an AUC of 0.825 (P < 0.001) in an ROC analysis. Significantly, immunohistochemical analyses demonstrated a high coexpression of MMP-9 and NGAL (P < 0.001) and high expression of ADAM12 (P < 0.001) in gastric cancer tissues compared with adjacent normal tissues (N = 35). In summary, uMMP-9/NGAL and uADAM12 are potential noninvasive biomarkers for gastric cancer, including early-stage disease.


Subject(s)
ADAM Proteins/urine , Acute-Phase Proteins/urine , Adenocarcinoma/diagnosis , Biomarkers, Tumor/urine , Lipocalins/urine , Matrix Metalloproteinase 9/urine , Membrane Proteins/urine , Proto-Oncogene Proteins/urine , Stomach Neoplasms/diagnosis , ADAM12 Protein , Adenocarcinoma/urine , Adult , Aged , Aged, 80 and over , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Lipocalin-2 , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Prognosis , Prospective Studies , Protein Array Analysis , ROC Curve , Stomach Neoplasms/urine , Young Adult
20.
Biosens Bioelectron ; 67: 465-71, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25223554

ABSTRACT

We present a microfluidic optoelectronic sensor for saliva diagnostics with a potential application for non-invasive early diagnosis of stomach cancer. Stomach cancer is the second most common cause of cancer-related deaths in the world. The primary identified cause is infection by a gram-negative bacterium Helicobacter pylori. These bacteria secrete the enzyme urease that converts urea into carbon dioxide (CO2) and ammonia (NH3), leading to their elevated levels in breath and body fluids. The proposed optoelectronic sensor will detect clinically relevant levels of CO2 and NH3 in saliva that can potentially be used for early diagnosis of stomach cancer. The sensor is composed of the embedded in a microfluidic device array of microwells filled with ion-exchange polymer microbeads doped with various organic dyes. The optical response of this unique highly diverse sensor is monitored over a broad spectrum, which provides a platform for cross-reactive sensitivity and allows detection of CO2 and NH3 in saliva at ppm levels.


Subject(s)
Ammonia/isolation & purification , Biosensing Techniques , Carbon Dioxide/urine , Stomach Neoplasms/urine , Early Detection of Cancer , Helicobacter pylori/enzymology , Helicobacter pylori/pathogenicity , Humans , Microfluidic Analytical Techniques , Stomach Neoplasms/microbiology , Urease/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...